The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020. In its recommendations, the society prioritzied the following:
* an appropriate balance between basic and applied research;
* emphasis on scientific excellence in funding proposals;
* funding for basic research that involves human germline modification;
* increase in investment for biomedical research.
Please contact the ISSCR Policy Director, Eric Anthony with any questions about these comments or other policy and advocacy efforts.
ISSCR Comments on Horizon Europe
Previous
Previous
ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products
Next
Next